Skip to content
★ Sign in to follow
DY

Di Yu

Elicera Therapeutics AB (publ)Elicera Therapeutics AB
Total declarations
7
Companies
2
▲ Purchases (1 ops.)
€5,128
▼ Sales (0 ops.)
—

Latest filing published 11 Mar 2025 for Elicera Therapeutics AB (publ), €8,427.

Filing timeline

BuySale
Di Yu

Insider track record

Disclosed buys
1
Disclosed sells
0
Signal history

Closed purchases

Market purchases
1

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Di Yu: trading record in brief

Filings by Di Yu span 2 companies, the busiest being Elicera Therapeutics AB (publ) and Elicera Therapeutics AB. Between 10 June 2021 and 11 March 2025, the trades on record add up to 7 filings.

On the market, this insider has only ever bought: 1 purchase, €5,128 in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 2 share grants.

The record was last updated on 11 March 2025 with a transaction (€8,427) in Elicera Therapeutics AB (publ). The last insider purchase was made public on 5 July 2021, 1,952 days ago. Half of the filings or more reach the Finansinspektionen feed on the day of the trade. Under the Market Abuse Regulation, managers have three business days to notify their trades. This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.

Companies and markets linked to Di Yu

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ●
    StyrelsesuppleantExecutivesElicera Therapeutics AB (publ)
    92,500 SEK13FI-SE
    50,000 shares@ SEK 1.8558.5% of flowInterimsaktieISIN SE0024173025FI:csv-12b51596af8b2383f883
  • ●
    StyrelsesuppleantExecutivesElicera Therapeutics AB
    199,989 SEK0FI-SE
    12,345 shares@ SEK 16.2077.7% of flowBTU (betald tecknad unit)ISIN SE0021626306FI:csv-0022345047b45d987cf5
  • ●
    StyrelsesuppleantExecutivesElicera Therapeutics AB
    0FI-SE
    2,583,334 shares0AktieISIN SE0015382080FI:csv-62a225dc8be56bbe950c
  • ▲
    StyrelsesuppleantExecutivesElicera Therapeutics AB
    52,030 SEK24FI-SE
    12,100 shares@ SEK 4.3022.3% of flowAktieISIN SE0015382080FI:csv-9db4a2e7ad3bff1fa1be
    Canonical exit: 3 Oct 2021 (T+90)
  • ●
    StyrelsesuppleantExecutivesElicera Therapeutics AB (publ)
    0FI-SE
    2,583,334 shares0AktieISIN SE0015382080FI:csv-d446273cd44107e4bb0d
  • ◆
    StyrelsesuppleantExecutivesElicera Therapeutics AB (publ)
    60,000 SEK15FI-SE
    7,500 shares@ SEK 8.00100.0% of flowAktieISIN SE0015382080FI:csv-b5086a594c136fae14d7
  • ◆
    StyrelsesuppleantExecutivesElicera Therapeutics AB (publ)
    0FI-SE
    7,500 shares0OptionISIN SE0015988233FI:csv-768719b79df0b0802bcc

7 of 7 declarations